Css LLC Vertex Pharmaceuticals Inc Put Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $4.39 Million - $5.01 Million	15,500 Added 620.0%	18,000 $5.67 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $714,400 - $803,700	2,500 New	2,500 $721,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $598,587 - $669,867	3,300 Added 6.9%	51,100 $9.27 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $8.96 Million - $10.6 Million	47,800 New	47,800 $9.64 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.